Abstract
This systematic literature review and meta-analysis evaluated the impact of residual disease (RD) status on overall survival (OS) and progression-free survival (PFS) in adults aged ≥18 years with ovarian cancer who had undergone primary debulking or interval debulking surgery.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Annals of oncology : official journal of the European Society for Medical Oncology
Paper Title
Journal
Date
